April 2, 2018

Contact: (610) 413-2987
info@pneumodose.com
 

PneumoDose and In-Tox Products Announce Release of the In Vitro Exposure System

Alexandria, VA – PneumoDose, LLC, a northern Virginia-based pharmaceutical technology company and In-Tox Products, LLC have developed a novel in vitro aerosol exposure system.

This novel system is a highly configurable platform that can be used to expose cell cultures and tissues to gases and vapors, aerosolized bacterial cells and spores, fungi, viruses, fibers, nanoparticles, and chemical test articles. Primary epithelial lung cells may be used to investigate pulmonary host responses. Additionally, dermal and corneal cell cultures may be used for external tissue exposure simulations.

In-Tox Products is one of the largest manufacturers of aerosol products in the United States, with over 50 years of providing quality aerosol equipment worldwide.  PneumoDose is a veteran-owned pharmaceutical technology company founded by a team of scientists and engineers with decades of combined experience in GLP-compliant aerosol research.  The companies joined forces in January of 2018 to deliver advanced aerosol testing products to the pharmaceutical market.  The In Vitro Exposure System is their first joint product.